Skip to main content
Coreline Soft Co., Ltd logo

Coreline Soft Co., Ltd — Investor Relations & Filings

Ticker · 384470 ISIN · KR7384470001 KO Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Filings indexed 163 across all filing types
Latest filing 2025-09-22 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 384470

About Coreline Soft Co., Ltd

https://www.corelinesoft.com/en/

Coreline Soft is a medical artificial intelligence company specializing in the development of software solutions for the analysis of thoracic medical images. Its flagship AI platform, AVIEW, is designed for healthcare professionals to automate and streamline diagnostic workflows. The platform utilizes Explainable AI (XAI) to analyze chest CT scans, enabling the simultaneous detection and quantification of multiple conditions from a single scan. Key applications include lung cancer screening through pulmonary nodule analysis, COPD assessment via emphysema quantification, and coronary artery calcification analysis. The company's technology focuses on facilitating the early detection of diseases, often before the onset of clinical symptoms, to improve diagnostic accuracy and efficiency.

Recent filings

Filing Released Lang Actions
전환주식의전환가액조정 (전환우선주)
Share Issue/Capital Change Classification · 88% confidence The document is a corporate disclosure regarding the adjustment of the conversion price of convertible preferred shares. This relates to a change in the company’s capital structure (conversion terms of issued shares), not an earnings release, report publication, or management update. It is an announcement of a capital change event. This fits the “Share Issue/Capital Change” category (SHA).
2025-09-22 Korean
합병등종료보고서(자산양수도)
M&A Activity Classification · 83% confidence The document is a Korean ‘합병등 종료보고서’ (Merger etc Termination Report) detailing the completion of an asset transfer (VUNO Med-LungCT) between CorelineSoft and VUNO, including transaction details, schedules, and before/after summary financials. This is a post-completion M&A announcement. Therefore, it falls under M&A Activity (TAR).
2025-09-22 Korean
소송등의판결ㆍ결정(일정금액이상의청구) (해고무효확인)
Legal Proceedings Report Classification · 100% confidence The document is a formal regulatory disclosure regarding a court judgment ('소송등의판결ㆍ결정') concerning a lawsuit ('해고무효확인'). It details the court's decision, the parties involved, and the company's future legal strategy. This falls under the category of legal proceedings and regulatory disclosures regarding litigation.
2025-09-19 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and is explicitly marked as a '정정신고' (Amendment Report). It details changes to previously reported stock option grants, including adjustments to the number of recipients, the number of shares, and the exercise price due to employee departures. This type of filing is a standard regulatory disclosure regarding capital structure and equity compensation, which falls under the 'Regulatory Filings' category as it does not fit into specific categories like 'Director's Dealing' (which is for personal trades) or 'Remuneration Information' (which is for executive compensation packages).
2025-09-18 Korean
반기보고서 (2025.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for Coreline Soft, covering the period from January 1, 2025, to June 30, 2025. It contains comprehensive financial and business information, including company overview, history, capital changes, and business descriptions, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2025
2025-08-14 Korean
전환주식의전환가액조정 (전환우선주)
Share Issue/Capital Change Classification · 100% confidence The document is an official regulatory filing regarding the adjustment of the conversion price of convertible preferred shares for Coreline Soft. It details the specific price changes, the reasons for the adjustment (market price decline), and the impact on the number of convertible shares. This type of disclosure regarding capital structure changes and share conversion terms falls under the category of share issue and capital changes.
2025-06-23 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.